Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)

NCT05164653 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Sacubitril Valsartan Sodium Hydrate
DRUG: Standard treatment

Sponsor

Saga University